phase i study of ven/aza maintenance therapy following ven/flubu2 ric allosct in high-risk mds/aml
Published 1 year ago • 207 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
2:22
the efficacy of ven-aza salvage therapy compared to azacitidine monotherapy in r/r aml
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
1:12
phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:18
phase ib study of venetoclax plus azacitidine in patients with r/r mds
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:55
viale-t: ven aza after allohsct in aml
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
2:33
a retrospective study assessing ven-aza versus aza alone for treating aml in first relapse
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
1:19
insights into a phase i/ia study of venetoclax, ixazomib and dexamethasone for r/r al amyloidosis
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
2:17
ventograft trial: aza, ven, and dli in patients with mds and aml who have relapsed following allosct
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
0:48
an ongoing phase i/ii dose-finding study of zn-d5 for r/r al amyloidosis